NUTX
Income statement / Annual
Last year (2024), Nutex Health, Inc.'s total revenue was $479.95 M,
an increase of 93.80% from the previous year.
In 2024, Nutex Health, Inc.'s net income was $52.18 M.
See Nutex Health, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$479.95 M |
$247.65 M |
$219.29 M |
$331.53 M |
$274.03 M |
$97.06 M |
$91.37 K |
$53.65 K |
$0.00 |
$0.00 |
| Cost of Revenue |
$283.69 M
|
$212.87 M
|
$203.87 M
|
$152.25 M
|
$116.42 M
|
$0.00
|
$62.30 K
|
$564.37 K
|
$473.00
|
$662.00
|
| Gross Profit |
$196.26 M
|
$34.77 M
|
$15.42 M
|
$179.28 M
|
$157.61 M
|
$97.06 M
|
$29.08 K
|
-$510.72 K
|
-$473.00
|
-$662.00
|
| Gross Profit Ratio |
0.41
|
0.14
|
0.07
|
0.54
|
0.58
|
1
|
0.32
|
-9.52
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$285.88 K
|
$0.00
|
$0.00
|
$545.22 K
|
$25.65 K
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$58.56 M
|
$33.23 M
|
$20.00 M
|
$5.46 M
|
$4.43 M
|
$59.87 M
|
$1.16 M
|
$1.81 M
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$2.84 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$58.56 M
|
$36.07 M
|
$20.00 M
|
$5.46 M
|
$4.43 M
|
$59.87 M
|
$1.16 M
|
$1.81 M
|
$448.12 K
|
$532.33 K
|
| Other Expenses |
$7.08 M
|
$30.48 M
|
$402.02 M
|
$3.27 M
|
$0.00
|
$2.48 M
|
$633.57 K
|
$3.87 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$65.64 M
|
$66.55 M
|
$422.02 M
|
$9.02 M
|
$4.43 M
|
$62.35 M
|
$1.80 M
|
$5.69 M
|
$448.12 K
|
$532.33 K
|
| Cost And Expenses |
$349.33 M
|
$279.42 M
|
$625.89 M
|
$161.27 M
|
$120.86 M
|
$62.35 M
|
$1.86 M
|
$5.69 M
|
$448.60 K
|
$532.99 K
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$114.00
|
$4.00
|
| Interest Expense |
$19.93 M
|
$16.32 M
|
$12.49 M
|
$6.20 M
|
$6.43 M
|
$3.53 M
|
-$642.07 K
|
-$367.35 K
|
$2.58 K
|
$3.15 K
|
| Depreciation & Amortization |
$18.97 M
|
$17.59 M
|
$13.13 M
|
$7.76 M
|
$5.90 M
|
$2.48 M
|
$522.00
|
$535.02 K
|
$473.00
|
$662.00
|
| EBITDA |
$148.65 M |
-$14.58 M |
-$394.03 M |
$183.45 M |
$158.07 M |
$38.10 M |
-$839.81 K |
-$5.11 M |
-$448.01 K |
-$532.32 K |
| EBITDA Ratio |
0.31
|
-0.06
|
-1.8
|
0.55
|
0.58
|
0.39
|
-9.19
|
-95.16
|
0
|
0
|
| Operating Income Ratio |
0.27
|
-0.13
|
-1.85
|
0.51
|
0.56
|
0.36
|
-20.03
|
-106.12
|
0
|
0
|
| Total Other Income/Expenses Net |
-$20.87 M
|
-$16.72 M
|
-$13.05 M
|
-$773.88 K
|
-$7.43 M
|
-$2.62 M
|
-$983.68 K
|
-$314.55 K
|
-$2.46 K
|
-$3.14 K
|
| Income Before Tax |
$109.75 M
|
-$48.49 M
|
-$419.65 M
|
$169.49 M
|
$145.74 M
|
$32.09 M
|
-$2.81 M
|
$582.06 K
|
-$451.06 K
|
-$536.13 K
|
| Income Before Tax Ratio |
0.23
|
-0.2
|
-1.91
|
0.51
|
0.53
|
0.33
|
-30.8
|
10.85
|
0
|
0
|
| Income Tax Expense |
$14.48 M
|
-$5.07 M
|
$13.09 M
|
$965.73 K
|
$181.34 K
|
$0.00
|
-$161.14 K
|
-$535.02 K
|
$0.00
|
$0.00
|
| Net Income |
$52.18 M
|
-$45.79 M
|
-$424.78 M
|
$132.59 M
|
$105.97 M
|
$20.92 M
|
-$2.81 M
|
$582.06 K
|
-$7.43 M
|
$83.81 K
|
| Net Income Ratio |
0.11
|
-0.18
|
-1.94
|
0.4
|
0.39
|
0.22
|
-30.8
|
10.85
|
0
|
0
|
| EPS |
10.23 |
-10.39 |
-100.5 |
33.55 |
24.69 |
3.98 |
-0.39 |
0.14 |
-3.6 |
0.0406 |
| EPS Diluted |
9.71 |
-10.39 |
-100.36 |
33.55 |
24.69 |
3.98 |
-0.39 |
0.14 |
-3.6 |
0.0406 |
| Weighted Average Shares Out |
$5.10 M
|
$4.41 M
|
$4.23 M
|
$4.02 M
|
$4.29 M
|
$4.14 M
|
$7.18 M
|
$4.18 M
|
$2.07 M
|
$2.07 M
|
| Weighted Average Shares Out Diluted |
$5.10 M
|
$4.41 M
|
$4.23 M
|
$3.95 M
|
$4.29 M
|
$4.14 M
|
$7.18 M
|
$4.18 M
|
$2.07 M
|
$2.07 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
